PHR3408

Repaglinide

pharmaceutical secondary standard, certified reference material

Manufacturer: Supelco

CAS Number: 135062-02-1

Synonym(S): Repaglinide, (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid, Novonorm, Prandin

Select a Size

Pack Size SKU Availability Price
400 MG PHR3408-400-MG In Stock ₹ 24,756.78

PHR3408 - 400 MG

₹ 24,756.78

In Stock

Quantity

1

Base Price: ₹ 24,756.78

GST (18%): ₹ 4,456.22

Total Price: ₹ 29,213.00

grade

certified reference materialpharmaceutical secondary standard

Quality Level

300

Agency

traceable to Ph. Eur. Y0000457traceable to USP 1600813

API family

repaglinide

CofA

current certificate can be downloaded

packaging

pkg of 400 mg

application(s)

pharmaceutical

storage temp.

2-30°C

SMILES string

CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3)ccc1C(O)=O

InChI

1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1

Related Products

Img

Supelco

PHR3131

pharmaceutical secondary standard, ...

Img

Supelco

PHR3553

certified reference material, pharm...

Img

Supelco

PHR3567

--

Img

Supelco

PHR3772

certified reference material, pharm...

Img

Supelco

PHR3146

pharmaceutical secondary standard, ...

Description

  • General description: Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
  • Application: These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
  • Biochem/physiol Actions: Repaglinide is a potent short-acting insulin secretagogue that acts by closing ATP-sensitive potassium (KATP) channels in the plasma membrane of the pancreatic beta cell. It represents a new class of insulin secretagogues, structurally unrelated to sulphonylureas, which were developed for the treatment of type 2 diabetes.
  • Analysis Note: These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
  • Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

SAFETY INFORMATION

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable